Image Courtesy : www.ucla.edu

The Centers for Disease Control and Prevention has awarded a $13.6 million grant to David Geffen School of Medicine at University of California Los Angeles. The grant has been provided to study the effectiveness of vaccines of COVID and the infections's long-term impact among U.S. health care workers.

Under this new yearlong project, the 2020–21 PREVENT I (Preventing Emerging Infections Through Vaccine Effectiveness Testing) study will be followed which, along with others, demonstrated the real-world benefit of mRNA vaccines to prevent symptomatic infection following their Food and Drug Administration authorisation.

In association with Carver College of Medicine of University of Iowa, PREVENT II will examine the effectiveness of both initial vaccinations and of boosters, along with the newly authorised for specific virus variants, informed Dr. David Talan, Prof., Emergency Medicine and Infectious Diseases at the Geffen School.

Under this project, 15,000 health care personnel will be enrolled at academic medical centers across the nation. The research will be led by Dr. Nicholas Mohr, Professor of Emergency Medicine, Anesthesia and Epidemiology at the University of Iowa, with Talan.

The results of the research will help in determining the effectiveness of the vaccines and boosters to prevent infection and to lessen the infection impacts.

Source: ucla.edu